ID GSLG1_HUMAN Reviewed; 1179 AA. AC Q92896; B7Z8Y4; D3DUJ7; Q13221; Q6P9D1; DT 26-SEP-2001, integrated into UniProtKB/Swiss-Prot. DT 16-DEC-2008, sequence version 2. DT 27-MAR-2024, entry version 197. DE RecName: Full=Golgi apparatus protein 1; DE AltName: Full=CFR-1; DE AltName: Full=Cysteine-rich fibroblast growth factor receptor; DE AltName: Full=E-selectin ligand 1; DE Short=ESL-1; DE AltName: Full=Golgi sialoglycoprotein MG-160; DE Flags: Precursor; GN Name=GLG1; Synonyms=CFR1, ESL1, MG160; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND FUNCTION. RC TISSUE=Fetal brain, and Lymphoblast; RX PubMed=8985126; DOI=10.1089/dna.1996.15.1121; RA Mourelatos Z., Gonatas J.O., Cinato E., Gonatas N.K.; RT "Cloning and sequence analysis of the human MG160, a fibroblast growth RT factor and E-selectin binding membrane sialoglycoprotein of the Golgi RT apparatus."; RL DNA Cell Biol. 15:1121-1128(1996). RN [2] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). RA Wu M., Chen J., Tan Y.H., Hong W.J., Ting R.; RL Submitted (JUN-1995) to the EMBL/GenBank/DDBJ databases. RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3). RC TISSUE=Trachea; RX PubMed=14702039; DOI=10.1038/ng1285; RA Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., RA Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., RA Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S., RA Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K., RA Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H., RA Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M., RA Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K., RA Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T., RA Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M., RA Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S., RA Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H., RA Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K., RA Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N., RA Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., RA Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., RA Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., RA Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B., RA Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y., RA Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K., RA Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T., RA Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T., RA Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y., RA Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H., RA Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y., RA Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H., RA Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O., RA Isogai T., Sugano S.; RT "Complete sequencing and characterization of 21,243 full-length human RT cDNAs."; RL Nat. Genet. 36:40-45(2004). RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=15616553; DOI=10.1038/nature03187; RA Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., She X., Xie G., RA Hellsten U., Chan Y.M., Altherr M., Couronne O., Aerts A., Bajorek E., RA Black S., Blumer H., Branscomb E., Brown N.C., Bruno W.J., Buckingham J.M., RA Callen D.F., Campbell C.S., Campbell M.L., Campbell E.W., Caoile C., RA Challacombe J.F., Chasteen L.A., Chertkov O., Chi H.C., Christensen M., RA Clark L.M., Cohn J.D., Denys M., Detter J.C., Dickson M., RA Dimitrijevic-Bussod M., Escobar J., Fawcett J.J., Flowers D., Fotopulos D., RA Glavina T., Gomez M., Gonzales E., Goodstein D., Goodwin L.A., Grady D.L., RA Grigoriev I., Groza M., Hammon N., Hawkins T., Haydu L., Hildebrand C.E., RA Huang W., Israni S., Jett J., Jewett P.B., Kadner K., Kimball H., RA Kobayashi A., Krawczyk M.-C., Leyba T., Longmire J.L., Lopez F., Lou Y., RA Lowry S., Ludeman T., Manohar C.F., Mark G.A., McMurray K.L., Meincke L.J., RA Morgan J., Moyzis R.K., Mundt M.O., Munk A.C., Nandkeshwar R.D., RA Pitluck S., Pollard M., Predki P., Parson-Quintana B., Ramirez L., Rash S., RA Retterer J., Ricke D.O., Robinson D.L., Rodriguez A., Salamov A., RA Saunders E.H., Scott D., Shough T., Stallings R.L., Stalvey M., RA Sutherland R.D., Tapia R., Tesmer J.G., Thayer N., Thompson L.S., Tice H., RA Torney D.C., Tran-Gyamfi M., Tsai M., Ulanovsky L.E., Ustaszewska A., RA Vo N., White P.S., Williams A.L., Wills P.L., Wu J.-R., Wu K., Yang J., RA DeJong P., Bruce D., Doggett N.A., Deaven L., Schmutz J., Grimwood J., RA Richardson P., Rokhsar D.S., Eichler E.E., Gilna P., Lucas S.M., RA Myers R.M., Rubin E.M., Pennacchio L.A.; RT "The sequence and analysis of duplication-rich human chromosome 16."; RL Nature 432:988-994(2004). RN [5] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RA Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., RA Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., RA Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., RA Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H., RA Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K., RA Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D., RA Hunkapiller M.W., Myers E.W., Venter J.C.; RL Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases. RN [6] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2). RC TISSUE=Testis; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [7] RP SUBCELLULAR LOCATION. RX PubMed=2355176; DOI=10.1177/38.7.2355176; RA Croul S., Mezitis S.G.E., Stieber A., Chen Y.J., Gonatas J.O., Goud B., RA Gonatas N.K.; RT "Immunocytochemical visualization of the Golgi apparatus in several RT species, including human, and tissues with an antiserum against MG-160, a RT sialoglycoprotein of rat Golgi apparatus."; RL J. Histochem. Cytochem. 38:957-963(1990). RN [8] RP TISSUE SPECIFICITY. RX PubMed=9182700; DOI=10.1042/bj3240427; RA Olofsson A., Hellman U., Ten Dijke P., Grimsby S., Ichijo H., Moren A., RA Miyazono K., Heldin C.-H.; RT "Latent transforming growth factor-beta complex in Chinese hamster ovary RT cells contains the multifunctional cysteine-rich fibroblast growth factor RT receptor, also termed E-selectin-ligand or MG-160."; RL Biochem. J. 324:427-434(1997). RN [9] RP GLYCOSYLATION AT ASN-677. RX PubMed=12754519; DOI=10.1038/nbt827; RA Zhang H., Li X.-J., Martin D.B., Aebersold R.; RT "Identification and quantification of N-linked glycoproteins using RT hydrazide chemistry, stable isotope labeling and mass spectrometry."; RL Nat. Biotechnol. 21:660-666(2003). RN [10] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Cervix carcinoma; RX PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007; RA Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R., RA Greff Z., Keri G., Stemmann O., Mann M.; RT "Kinase-selective enrichment enables quantitative phosphoproteomics of the RT kinome across the cell cycle."; RL Mol. Cell 31:438-448(2008). RN [11] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1201 (ISOFORM 2), RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1190 (ISOFORM 3), AND RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Cervix carcinoma; RX PubMed=20068231; DOI=10.1126/scisignal.2000475; RA Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L., RA Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.; RT "Quantitative phosphoproteomics reveals widespread full phosphorylation RT site occupancy during mitosis."; RL Sci. Signal. 3:RA3-RA3(2010). RN [12] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=21269460; DOI=10.1186/1752-0509-5-17; RA Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., RA Bennett K.L., Superti-Furga G., Colinge J.; RT "Initial characterization of the human central proteome."; RL BMC Syst. Biol. 5:17-17(2011). RN [13] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Liver; RX PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014; RA Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L., RA Ye M., Zou H.; RT "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver RT phosphoproteome."; RL J. Proteomics 96:253-262(2014). RN [14] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=25944712; DOI=10.1002/pmic.201400617; RA Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D., RA Lane L., Bairoch A., Van Dorsselaer A., Carapito C.; RT "N-terminome analysis of the human mitochondrial proteome."; RL Proteomics 15:2519-2524(2015). CC -!- FUNCTION: Binds fibroblast growth factor and E-selectin (cell-adhesion CC lectin on endothelial cells mediating the binding of neutrophils). CC {ECO:0000269|PubMed:8985126}. CC -!- SUBCELLULAR LOCATION: Golgi apparatus membrane CC {ECO:0000269|PubMed:2355176}; Single-pass type I membrane protein CC {ECO:0000255}. Golgi outpost {ECO:0000250|UniProtKB:Q62638}. Cytoplasm, CC cytoskeleton, microtubule organizing center CC {ECO:0000250|UniProtKB:Q62638}. Note=Golgi medial cisternae. Localizes CC to the postsynaptic Golgi apparatus region, also named Golgi outpost, CC which shapes dendrite morphology by functioning as sites of CC acentrosomal microtubule nucleation. {ECO:0000250|UniProtKB:Q62638}. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=3; CC Name=1; CC IsoId=Q92896-1; Sequence=Displayed; CC Name=2; CC IsoId=Q92896-2; Sequence=VSP_035998; CC Name=3; CC IsoId=Q92896-3; Sequence=VSP_043472, VSP_035998; CC -!- TISSUE SPECIFICITY: Widely expressed. Highest levels in pancreas, CC skeletal muscle, placenta, heart, testis and ovary. Also found in the CC kidney, liver, lung and brain. {ECO:0000269|PubMed:9182700}. CC -!- DEVELOPMENTAL STAGE: Expressed both in adult and fetal tissues. CC -!- PTM: Fucosylation is essential for binding to E-selectin. CC {ECO:0000250|UniProtKB:Q61543}. CC -!- PTM: N-glycosylated. Contains sialic acid residues. CC {ECO:0000250|UniProtKB:Q62638}. CC -!- SEQUENCE CAUTION: CC Sequence=AAB02178.1; Type=Frameshift; Evidence={ECO:0000305}; CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; U64791; AAB06460.1; -; mRNA. DR EMBL; U28811; AAB02178.1; ALT_FRAME; mRNA. DR EMBL; AK304156; BAH14120.1; -; mRNA. DR EMBL; AC009053; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; AC009153; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; AC109599; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; CH471114; EAW95683.1; -; Genomic_DNA. DR EMBL; CH471114; EAW95682.1; -; Genomic_DNA. DR EMBL; CH471114; EAW95686.1; -; Genomic_DNA. DR EMBL; BC060822; AAH60822.1; -; mRNA. DR CCDS; CCDS32485.1; -. [Q92896-2] DR CCDS; CCDS45526.1; -. [Q92896-3] DR CCDS; CCDS45527.1; -. [Q92896-1] DR RefSeq; NP_001139138.1; NM_001145666.1. [Q92896-3] DR RefSeq; NP_001139139.1; NM_001145667.1. [Q92896-1] DR RefSeq; NP_036333.2; NM_012201.5. [Q92896-2] DR AlphaFoldDB; Q92896; -. DR SMR; Q92896; -. DR BioGRID; 108996; 129. DR CORUM; Q92896; -. DR DIP; DIP-27582N; -. DR IntAct; Q92896; 38. DR MINT; Q92896; -. DR STRING; 9606.ENSP00000205061; -. DR GlyConnect; 1280; 42 N-Linked glycans (4 sites). DR GlyCosmos; Q92896; 7 sites, 41 glycans. DR GlyGen; Q92896; 12 sites, 40 N-linked glycans (4 sites), 3 O-linked glycans (7 sites). DR iPTMnet; Q92896; -. DR MetOSite; Q92896; -. DR PhosphoSitePlus; Q92896; -. DR SwissPalm; Q92896; -. DR BioMuta; GLG1; -. DR DMDM; 218512060; -. DR EPD; Q92896; -. DR jPOST; Q92896; -. DR MassIVE; Q92896; -. DR MaxQB; Q92896; -. DR PaxDb; 9606-ENSP00000205061; -. DR PeptideAtlas; Q92896; -. DR ProteomicsDB; 75578; -. [Q92896-1] DR ProteomicsDB; 75579; -. [Q92896-2] DR ProteomicsDB; 75580; -. [Q92896-3] DR Pumba; Q92896; -. DR Antibodypedia; 2273; 377 antibodies from 27 providers. DR DNASU; 2734; -. DR Ensembl; ENST00000205061.9; ENSP00000205061.5; ENSG00000090863.12. [Q92896-2] DR Ensembl; ENST00000422840.7; ENSP00000405984.3; ENSG00000090863.12. [Q92896-1] DR Ensembl; ENST00000447066.6; ENSP00000406946.2; ENSG00000090863.12. [Q92896-3] DR GeneID; 2734; -. DR KEGG; hsa:2734; -. DR MANE-Select; ENST00000422840.7; ENSP00000405984.3; NM_001145667.2; NP_001139139.1. DR UCSC; uc002fcw.5; human. [Q92896-1] DR AGR; HGNC:4316; -. DR CTD; 2734; -. DR DisGeNET; 2734; -. DR GeneCards; GLG1; -. DR HGNC; HGNC:4316; GLG1. DR HPA; ENSG00000090863; Low tissue specificity. DR MIM; 600753; gene. DR neXtProt; NX_Q92896; -. DR OpenTargets; ENSG00000090863; -. DR PharmGKB; PA28719; -. DR VEuPathDB; HostDB:ENSG00000090863; -. DR eggNOG; KOG3648; Eukaryota. DR GeneTree; ENSGT00390000011262; -. DR HOGENOM; CLU_011063_0_0_1; -. DR InParanoid; Q92896; -. DR OMA; MECLIEH; -. DR OrthoDB; 311808at2759; -. DR PhylomeDB; Q92896; -. DR TreeFam; TF106112; -. DR PathwayCommons; Q92896; -. DR Reactome; R-HSA-202733; Cell surface interactions at the vascular wall. DR SignaLink; Q92896; -. DR BioGRID-ORCS; 2734; 18 hits in 1157 CRISPR screens. DR ChiTaRS; GLG1; human. DR GeneWiki; GLG1; -. DR GenomeRNAi; 2734; -. DR Pharos; Q92896; Tbio. DR PRO; PR:Q92896; -. DR Proteomes; UP000005640; Chromosome 16. DR RNAct; Q92896; Protein. DR Bgee; ENSG00000090863; Expressed in stromal cell of endometrium and 222 other cell types or tissues. DR ExpressionAtlas; Q92896; baseline and differential. DR GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB. DR GO; GO:0031012; C:extracellular matrix; IEA:Ensembl. DR GO; GO:0005794; C:Golgi apparatus; IDA:HPA. DR GO; GO:0000139; C:Golgi membrane; IBA:GO_Central. DR GO; GO:0016020; C:membrane; HDA:UniProtKB. DR GO; GO:0005815; C:microtubule organizing center; IEA:UniProtKB-SubCell. DR GO; GO:0005886; C:plasma membrane; TAS:Reactome. DR GO; GO:0017134; F:fibroblast growth factor binding; IBA:GO_Central. DR GO; GO:0005102; F:signaling receptor binding; TAS:ProtInc. DR GO; GO:0060349; P:bone morphogenesis; IEA:Ensembl. DR GO; GO:0010955; P:negative regulation of protein processing; IEA:Ensembl. DR GO; GO:0030512; P:negative regulation of transforming growth factor beta receptor signaling pathway; IEA:Ensembl. DR GO; GO:0016485; P:protein processing; IEA:Ensembl. DR GO; GO:0032330; P:regulation of chondrocyte differentiation; IEA:Ensembl. DR GO; GO:0007179; P:transforming growth factor beta receptor signaling pathway; IEA:Ensembl. DR InterPro; IPR001893; Cys-rich_GLG1_repeat. DR InterPro; IPR017873; Cys-rich_GLG1_repeat_euk. DR InterPro; IPR039728; GLG1. DR PANTHER; PTHR11884:SF1; GOLGI APPARATUS PROTEIN 1; 1. DR PANTHER; PTHR11884; SELECTIN LIGAND RELATED; 1. DR Pfam; PF00839; Cys_rich_FGFR; 15. DR PROSITE; PS51289; GLG1_C_RICH; 16. DR Genevisible; Q92896; HS. PE 1: Evidence at protein level; KW Alternative splicing; Cytoplasm; Cytoskeleton; Glycoprotein; KW Golgi apparatus; Membrane; Phosphoprotein; Reference proteome; Repeat; KW Sialic acid; Signal; Transmembrane; Transmembrane helix. FT SIGNAL 1..29 FT /evidence="ECO:0000255" FT CHAIN 30..1179 FT /note="Golgi apparatus protein 1" FT /id="PRO_0000011120" FT TOPO_DOM 30..1145 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 1146..1166 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 1167..1179 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT REPEAT 116..149 FT /note="Cys-rich GLG1 1" FT REPEAT 150..212 FT /note="Cys-rich GLG1 2" FT REPEAT 215..278 FT /note="Cys-rich GLG1 3" FT REPEAT 286..346 FT /note="Cys-rich GLG1 4" FT REPEAT 347..413 FT /note="Cys-rich GLG1 5" FT REPEAT 414..473 FT /note="Cys-rich GLG1 6" FT REPEAT 475..537 FT /note="Cys-rich GLG1 7" FT REPEAT 538..604 FT /note="Cys-rich GLG1 8" FT REPEAT 609..668 FT /note="Cys-rich GLG1 9" FT REPEAT 670..728 FT /note="Cys-rich GLG1 10" FT REPEAT 729..788 FT /note="Cys-rich GLG1 11" FT REPEAT 796..856 FT /note="Cys-rich GLG1 12" FT REPEAT 858..911 FT /note="Cys-rich GLG1 13" FT REPEAT 912..979 FT /note="Cys-rich GLG1 14" FT REPEAT 980..1035 FT /note="Cys-rich GLG1 15" FT REPEAT 1041..1101 FT /note="Cys-rich GLG1 16" FT REGION 32..112 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 62..83 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT MOD_RES 961 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q61543" FT CARBOHYD 165 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 210 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 581 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 677 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000269|PubMed:12754519" FT CARBOHYD 786 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT VAR_SEQ 147..157 FT /note="Missing (in isoform 3)" FT /evidence="ECO:0000303|PubMed:14702039" FT /id="VSP_043472" FT VAR_SEQ 1179 FT /note="R -> RLQYRSETMAYKGLVWSQDVTGSPA (in isoform 2 and FT isoform 3)" FT /evidence="ECO:0000303|PubMed:14702039, FT ECO:0000303|PubMed:15489334" FT /id="VSP_035998" FT CONFLICT 33 FT /note="Q -> H (in Ref. 1; AAB06460)" FT /evidence="ECO:0000305" FT CONFLICT 67 FT /note="P -> L (in Ref. 1; AAB06460)" FT /evidence="ECO:0000305" FT CONFLICT 85 FT /note="P -> L (in Ref. 1; AAB06460)" FT /evidence="ECO:0000305" FT CONFLICT 99 FT /note="Missing (in Ref. 2; AAB02178)" FT /evidence="ECO:0000305" FT CONFLICT 526 FT /note="L -> S (in Ref. 2; AAB02178)" FT /evidence="ECO:0000305" FT CONFLICT 702 FT /note="N -> T (in Ref. 2; AAB02178)" FT /evidence="ECO:0000305" FT CONFLICT 707 FT /note="Missing (in Ref. 2; AAB02178)" FT /evidence="ECO:0000305" FT CONFLICT 1082 FT /note="I -> L (in Ref. 2; AAB02178)" FT /evidence="ECO:0000305" FT MOD_RES Q92896-2:1201 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:20068231" FT MOD_RES Q92896-3:1190 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:20068231" SQ SEQUENCE 1179 AA; 134552 MW; 390F9923DC83C300 CRC64; MAACGRVRRM FRLSAALHLL LLFAAGAEKL PGQGVHSQGQ GPGANFVSFV GQAGGGGPAG QQLPQLPQSS QLQQQQQQQQ QQQQPQPPQP PFPAGGPPAR RGGAGAGGGW KLAEEESCRE DVTRVCPKHT WSNNLAVLEC LQDVREPENE ISSDCNHLLW NYKLNLTTDP KFESVAREVC KSTITEIKEC ADEPVGKGYM VSCLVDHRGN ITEYQCHQYI TKMTAIIFSD YRLICGFMDD CKNDINILKC GSIRLGEKDA HSQGEVVSCL EKGLVKEAEE REPKIQVSEL CKKAILRVAE LSSDDFHLDR HLYFACRDDR ERFCENTQAG EGRVYKCLFN HKFEESMSEK CREALTTRQK LIAQDYKVSY SLAKSCKSDL KKYRCNVENL PRSREARLSY LLMCLESAVH RGRQVSSECQ GEMLDYRRML MEDFSLSPEI ILSCRGEIEH HCSGLHRKGR TLHCLMKVVR GEKGNLGMNC QQALQTLIQE TDPGADYRID RALNEACESV IQTACKHIRS GDPMILSCLM EHLYTEKMVE DCEHRLLELQ YFISRDWKLD PVLYRKCQGD ASRLCHTHGW NETSEFMPQG AVFSCLYRHA YRTEEQGRRL SRECRAEVQR ILHQRAMDVK LDPALQDKCL IDLGKWCSEK TETGQELECL QDHLDDLVVE CRDIVGNLTE LESEDIQIEA LLMRACEPII QNFCHDVADN QIDSGDLMEC LIQNKHQKDM NEKCAIGVTH FQLVQMKDFR FSYKFKMACK EDVLKLCPNI KKKVDVVICL STTVRNDTLQ EAKEHRVSLK CRRQLRVEEL EMTEDIRLEP DLYEACKSDI KNFCSAVQYG NAQIIECLKE NKKQLSTRCH QKVFKLQETE MMDPELDYTL MRVCKQMIKR FCPEADSKTM LQCLKQNKNS ELMDPKCKQM ITKRQITQNT DYRLNPMLRK ACKADIPKFC HGILTKAKDD SELEGQVISC LKLRYADQRL SSDCEDQIRI IIQESALDYR LDPQLQLHCS DEISSLCAEE AAAQEQTGQV EECLKVNLLK IKTELCKKEV LNMLKESKAD IFVDPVLHTA CALDIKHHCA AITPGRGRQM SCLMEALEDK RVRLQPECKK RLNDRIEMWS YAAKVAPADG FSDLAMQVMT SPSKNYILSV ISGSICILFL IGLMCGRITK RVTRELKDR //